Ocugen to seek emergency nod for Covaxin from Health Canada
Bharat Biotech’s US partner Ocugen said it will be seeking an emergency use nod for India’s first indigenously developed Covid-19 vaccine Covaxin from the Canadian health authorities. The company said it has already initiated discussions with Health Canada to seek regulatory approval.
💡 newsR Knowledge: Other News Mentions
Can person with any allergy take COVID-19 shots? Know what experts sayBharat Biotech, the manufacturer of the COVID-19 vaccine said that those who have known allergies to any component of Covaxin should not take the jab.
COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacyNovavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
Covid: Fresh cases fall to 76-day low, daily toll lowest in 2 monthsThe number of active cases of Covid-19 in India, which had swelled to over 37.2 lakh at the height of the second wave, has fallen below 10 lakh after 66 days.The..
'Love does conquer all, doesn't it?': Terminally ill bride to get her COVID-delayed weddingKat and Phil Southwell, are once again tweaking their wedding plans.
‘Silent tormentor’ Covid has raised risk of abuse for elderly: SurveyA new study on the impact of pandemic on the elderly shows that 58.2% of those surveyed were aware about Covid-19 vaccines and 78.7% of them felt getting..
You Might Like
Related videos from verified sources
Related news from verified sources